Thus, MCP-1 is a potential “intervention point” for the treatment of various inflammatory diseases, such as multiple sclerosis, rheumatoid arthritis, atherosclerosis, and insulin-resistant T2DM [3], [28–32]. Here, CCL2 is linked to rheumatoid arthritis.